Moderna Inc (MRNA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $90.38B
Last updated: Nov 17, 2026 at 11:06 AM ET
Moderna Inc (MRNA) Competitors
The companies most similar to Moderna are Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX) and argenx NV ADR (ARGX). By market cap, Moderna ranks 3rd of the 13 companies on this page; Vertex Pharmaceuticals (VRTX) is the largest at $136.56B. The median P/E of the 7 companies with a P/E is 30.0x.
Peer Comparison
MRNA's ROIC of -28.9% is below the peer median of 6.2%, and its revenue growth of 29.2% is above the median of 14.7%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Moderna (MRNA) | $90.38B | N/A | 34.2x | -110.5% | -28.9% | 29.2% | 0.00% |
| Regeneron Pharmaceuticals Inc (REGN) | $98.84B | 18.4x | 5.7x | 28.5% | 13.7% | 36.3% | 0.39% |
| Vertex Pharmaceuticals Inc (VRTX) | $136.56B | 30.0x | 10.5x | 30.7% | 14.2% | 11.8% | 0.00% |
| argenx NV ADR (ARGX) | $60.37B | 33.5x | 6.1x | 31.7% | N/A | 52.1% | 0.00% |
| BeOne Medicines AG (ONC) | $47.58B | 50.0x | 18.7x | 13.9% | 7.5% | 33.8% | 0.00% |
| Revolution Medicines Inc (RVMD) | $37.27B | N/A | 181.6x | 0.0% | -52.1% | -95.2% | 0.00% |
| Genmab AS (GMAB) | $31.67B | 35.8x | 19.2x | 17.0% | 4.8% | 16.1% | 0.00% |
| Royalty Pharma Plc (RPRX) | $39.85B | 12.9x | 11.7x | 25.7% | 7.6% | 13.3% | 1.37% |
| Insmed Inc (INSM) | $26.58B | N/A | 17.7x | -39.9% | -44.2% | 268.4% | 0.00% |
| Roivant Sciences Ltd (ROIV) | $28.64B | N/A | 679.3x | 0.0% | N/A | 2136.0% | 0.00% |
| Novavax Inc (NVAX) | $1.41B | N/A | 3.2x | -18.6% | -66.6% | -3.0% | 0.00% |
| MacroGenics Inc (MGNX) | $140.60M | N/A | 1.2x | -36.6% | -108.7% | -64.8% | 0.00% |
| CorMedix Inc (CRMD) | $370.64M | 6.3x | 0.9x | 15.5% | 13.9% | -47.7% | 0.00% |
| Peer median | $34.47B | 30.0x | 11.1x | 14.7% | 6.2% | 14.7% | 0.00% |
Similar Companies
These are the 12 companies most similar to Moderna, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Regeneron Pharmaceuticals Inc (REGN) | Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. | REGN competitors |
| Vertex Pharmaceuticals Inc (VRTX) | Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. | VRTX competitors |
| argenx NV ADR (ARGX) | argenx SE, a clinical-phase biotechnology company, focuses on the development of antibody-based therapies for the treatment of autoimmune diseases... | ARGX competitors |
| BeOne Medicines AG (ONC) | BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe... | ONC competitors |
| Revolution Medicines Inc (RVMD) | Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted... | RVMD competitors |
| Genmab AS (GMAB) | Genmab A / S develops antibody therapies for the treatment of cancer and other diseases mainly in Denmark. The company is headquartered in Copenhagen, Denmark. | GMAB competitors |
| Royalty Pharma Plc (RPRX) | Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. | RPRX competitors |
| Insmed Inc (INSM) | Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. | INSM competitors |
| Roivant Sciences Ltd (ROIV) | Roivant Sciences Ltd (ROIV) is a transformative biopharmaceutical company focused on advancing drug development and commercialization through a distinctive... | ROIV competitors |
| Novavax Inc (NVAX) | Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases... | NVAX competitors |
| MacroGenics Inc (MGNX) | MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States. | MGNX competitors |
| CorMedix Inc (CRMD) | CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious... | CRMD competitors |
Frequently Asked Questions About MRNA
Who are Moderna's main competitors?
The companies most similar to Moderna include Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), argenx NV ADR (ARGX), BeOne Medicines AG (ONC) and Revolution Medicines (RVMD), listed from the closest match.
Who is Moderna's biggest competitor?
Vertex Pharmaceuticals (VRTX) is the largest of the similar companies at $136.56B; Regeneron Pharmaceuticals (REGN) is the closest match by business profile, size, sector and industry.
How does MRNA stock compare with its competitors?
MRNA's P/S is 34.2x against a peer median of 11.1x; its net margin is -110.5% against a peer median of 14.7%.
Which of Moderna's competitors pays a higher dividend?
Moderna pays no dividend. Royalty Pharma Plc (RPRX) and Regeneron Pharmaceuticals (REGN) have higher forward dividend yields; Royalty Pharma Plc (RPRX) has the highest at 1.37%.
Is Moderna bigger than its competitors?
No. Moderna is 3rd by market cap among the 13 companies on this page; the largest is Vertex Pharmaceuticals (VRTX) at $136.56B.
MRNA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors